Recent Legal Developments at the FTC Related to Pharmaceuticals
In this flash update, Adam Acosta, Partner, White & Case LLP, provides an overview of recent developments at the FTC on antitrust enforcement in the pharmaceuticals sector. He discusses the FTC’s focus on pharmaceutical pricing, developments related to pharmaceutical mergers, and updates related to the FTC’s enforcement activity. From AHLA’s Antitrust Practice Group.
Watch Adam’s commentary here.